Cover Image
Saved in:

Follow-on biologics hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.

Bibliographic Details
Corporate Author: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Format: Government Document Online Book
Language:English
Published: Washington : U.S. G.P.O., 2008.
Series:S. hrg. ; 110-375
Subjects:
Online Access:ONLINE VERSION
ONLINE VERSION
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02411nam a2200397 a 4500
001 1122160
005 20081212120559.0
006 m d f
007 cr bn|||||||||
008 081117s2008 dcu sb f000 0 eng c
010 |a   
035 |a (OCoLC)272396761 
040 |a GPO  |c GPO  |d GPO  |d MvI 
042 |a pcc 
043 |a n-us--- 
049 |a WWW 
050 1 4 |a KF26  |b .L27 2007m 
074 |a 1043-A (online) 
086 0 |a Y 4.L 11/4:S.HRG.110-375 
110 1 |a United States.  |b Congress.  |b Senate.  |b Committee on Health, Education, Labor, and Pensions. 
245 1 0 |a Follow-on biologics  |h [electronic resource] :  |b hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007. 
260 |a Washington :  |b U.S. G.P.O.,  |c 2008. 
300 |a 1 electronic text (iv, 78 p.) :  |b HTML, digital, PDF file. 
490 1 |a S. hrg. ;  |v 110-375 
538 |a Mode of access: Internet from the GPO Access web site. Addresses as of 11/17/08: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110%5Fsenate%5Fhearings&docid=f:34053.wais (text version); http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110%5Fsenate%5Fhearings&docid=f:34053.pdf (PDF version) ; current access is available via PURLs. 
500 |a Title from title screen (viewed on Nov. 17, 2008). 
504 |a Includes bibliographical references. 
650 0 |a Pharmaceutical biotechnology  |x Government policy  |z United States. 
650 0 |a Pharmaceutical biotechnology  |z United States  |v Patents. 
650 0 |a Pharmaceutical technology  |x Government policy  |z United States. 
650 0 |a Drug development  |x Government policy  |z United States. 
776 0 |a United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.  |t Follow-on biologics  |h iv, 78 p.  |w (OCoLC)272403831 
810 1 |a United States.  |b Congress.  |b Senate.  |t S. hrg ;  |v 110-375. 
856 4 0 |3 Text version:  |u http://purl.access.gpo.gov/GPO/LPS105468  |z ONLINE VERSION 
856 4 0 |3 PDF version:  |u http://purl.access.gpo.gov/GPO/LPS105469  |z ONLINE VERSION 
852 0 |b WWW  |h KF26  |i .L27 2007m